Vascular embolization with an expansible implant
원문보기
IPC분류정보
국가/구분
United States(US) Patent
등록
국제특허분류(IPC7판)
G06T-007/60
A61F-002/06
B22C-007/02
B22C-007/00
출원번호
US-0733697
(2007-04-10)
등록번호
US-7483558
(2009-01-27)
발명자
/ 주소
Greene, Jr.,George R.
Rosenbluth,Robert F.
Cox,Brian J.
출원인 / 주소
MicroVention, Inc.
대리인 / 주소
Inskeep IP Group, Inc.
인용정보
피인용 횟수 :
10인용 특허 :
74
초록▼
A vascular implant formed of a compressible foam material has a compressed configuration from which it is expansible into a configuration substantially conforming to the shape and size of a vascular site to be embolized. Preferably, the implant is formed of a hydrophilic, macroporous foam material,
A vascular implant formed of a compressible foam material has a compressed configuration from which it is expansible into a configuration substantially conforming to the shape and size of a vascular site to be embolized. Preferably, the implant is formed of a hydrophilic, macroporous foam material, having an initial configuration of a scaled-down model of the vascular site, from which it is compressible into the compressed configuration. The implant is made by scanning the vascular site to create a digitized scan data set; using the scan data set to create a three-dimensional digitized virtual model of the vascular site; using the virtual model to create a scaled-down physical mold of the vascular site; and using the mold to create a vascular implant in the form of a scaled-down model of the vascular site. To embolize a vascular site, the implant is compressed and passed through a microcatheter, the distal end of which has been passed into a vascular site. Upon entering the vascular site, the implant expands in situ substantially to fill the vascular site. A retention element is contained within the microcatheter and has a distal end detachably connected to the implant. A flexible, tubular deployment element is used to pass the implant and the retention element through the microcatheter, and then to separate the implant from the retention element when the implant has been passed out of the microcatheter and into the vascular site.
대표청구항▼
What is claimed is: 1. A method of manufacturing a vascular implant, comprising: (a) imaging a vascular site to create a digitized scan data set; (b) creating a three-dimensional virtual model of the vascular site using the digitized scan data set; (c) forming a vascular implant device in the form
What is claimed is: 1. A method of manufacturing a vascular implant, comprising: (a) imaging a vascular site to create a digitized scan data set; (b) creating a three-dimensional virtual model of the vascular site using the digitized scan data set; (c) forming a vascular implant device in the form of a physical model of the vascular site using the virtual model; and (d) comprising the vascular implant device into a compressed configuration. 2. The method of claim 1, wherein the imaging of the vascular site is performed by scanning the vascular site. 3. The method of claim 2, wherein the scanning is performed by a technique selected from the group consisting of computer tomography, magnetic resonance imaging; magnetic resonance angiography, and ultrasound. 4. The method of claim 1, wherein the forming a vascular implant device comprises: (c)(1) creating a three-dimensional physical mold of the vascular site using the virtual model; and (c)(2) molding the vascular implant device in the form of the vascular site using the physical mold. 5. the molding of claim 4, wherein the molding of the vascular implant device includes injecting a hydrophilic polymeric foam material, in a liquid or semi-liquid state, into the molding. 6. The method of claim 4, wherein the creating of a physical mold comprises; ( c)(1)(i) translating the virtual model into a form that is usable by CAD/DAM software; and (c)(1)(ii) using the CAD/CAM software to create the physical mold by stereolithography. 7. The method of claim 4, wherein the molding the vascular implant device includes associating the vascular implant with a retention element. 8. The method of claim 1, wherein the vascular implant device is made from a hydrophilic polymeric foam. 9. The method of claim 1 wherein the compressing the vascular implant device to the compressed configuration includes reducing an outside diameter of the vascular implant device to less than an inside diameter of a microcatheter. 10. The method of claim 1 wherein the forming a vascular implant device comprises creating a scaled-down vascular implant device. 11. A method of embolizing a vascular site comprising the steps of: (a) scanning a vascular site to create a digitized scan data set; (b) creating a three-dimensional virtual model of the vascular site using the digitized scan data set; (c) forming a vascular implant in the form of the vascular site using the virtual model; (d) compressing the vascular implant into a compressed configuration; and (e) deploying the vascular implant at the vascular site. 12. The method of claim 11, wherein the scanning is performed by a technique selected from the group consisting of computer tomography, magnetic resonance imaging, magnetic resonance angiography, and ultrasound. 13. The method of claim 11, wherein the forming the vascular implant comprises: (c)(1) creating a three-dimensional physical mold of the vascular site using the virtual model; and (c)(2) molding the vascular implant in the form of the vascular site using the physical mold. 14. The method of claim 13, wherein the creating of a three-dimensional physical mold comprises; (c)(1)(i) translating the virtual model into a form that is usable by CAD/DAM software; and (c)(1)(ii) using the CAD/CAM software to create the physical mold by stereolithography. 15. The method of claim 13, wherein the molding the vascular implant includes injecting a hydrophilic polymeric material into the physical mold. 16. The method of claim 13, wherein the molding the vascular implant includes associating a retention element with the vascular implant. 17. The method of claim 11 wherein the compressing the vascular implant device to the compressed configuration includes reducing an outside diameter of the vascular implant device to less than an inside diameter of a microcatheter used to deliver said vascular implant device. 18. The method of claim 11 wherein the forming a vascular implant device comprises creating a scaled-down vascular implant device. 19. The method of claim 11 wherein the deploying the vascular implant at the vascular site comprises: (e)(1) passing the vascular implant through a microcatheter; (e)(2) expanding the vascular implant at the vascular site; and (e)(3) releasing the vascular implant from a retention element at the vascular site. 20. A method of manufacturing a vascular implant, comprising: (a) scanning a vascular site to create a digitized scan data set; (b) creating a three-dimensional virtual model of the vascular site using the digitized scan data set; (c) forming a vascular implant in the form of a physical model of the vascular site using the virtual model; and (d) associating the vascular implant with a retention element, substantially contemporaneously to said forming the vascular implant. 21. The method of claim 20, wherein the scanning the vascular site is performed by a technique selected from the group consisting of computer tomography, magnetic resonance imaging; magnetic resonance angiography, and ultrasound. 22. The method of claim 20, wherein the forming the vascular implant comprises: (c)(1) creating a three-dimensional physical mold of the vascular site using the virtual model; and (c)(2) molding the vascular implant in the form of the vascular site using the physical mold. 23. The method of claim 22, wherein the creating of the three-dimensional physical mold comprises; (c)(1)(i) translating the virtual model into a form that is usable by CAD/DAM software; and (c)(1)(ii) using the CAD/CAM software to create the physical mold by stereolithography. 24. The method of claim 22, wherein the molding of the vascular implant includes injecting a hydrophilic polymeric material into the physical mold. 25. A method of claim 20 further comprising compressing the vascular implant to a compressed configuration. 26. The method of claim 25 wherein the compressing the vascular implant to the compressed configuration includes reducing an outside diameter of the vascular implant device to less than an inside diameter of a microcatheter. 27. The method of claim 20 wherein the forming a vascular implant device comprises creating a scaled-down vascular implant device.
연구과제 타임라인
LOADING...
LOADING...
LOADING...
LOADING...
LOADING...
이 특허에 인용된 특허 (74)
Dwyer,Jeff; Chen,David; Chapman,M. Weston, Anatomical visualization and measurement system.
Erdman Arthur G. (New Brighton MN) Rekow Elizabeth D. (Fridley MN) Riley Donald R. (Edina MN) Klamecki Barney (Minneapolis MN) Zhu Yang (St. Paul MN) Ahn Jeong-Ho (Seoul KRX), Automated high-precision fabrication of objects of complex and unique geometry.
Greff Richard J. (Yorba Linda CA) Jones Michael L. (Capistrano Beach CA) Evans Scott (Santa Ana CA), Cellulose diacetate compositions for use in embolizing blood vessels.
Drohan William N. ; MacPhee Martin J. ; Miekka Shirley I. ; Singh Manish S. ; Elson Clive,CAX ; Taylor ; Jr. John R., Chitin hydrogels, methods of their production and use.
Leshchiner Adolf (Fairview NJ) Larsen Nancy E. (Southfield NY) Balazs Endre A. (Ft. Lee NJ) Hilal Sadek K. (Englewood Cliffs NJ), Compositions for therapeutic percutaneous embolization and the use thereof.
Dormandy ; Jr. Ray (San Bruno CA) Berlo Marcelyn A. (San Francisco CA) Paul David J. (Pleasanton CA), Embolization device and apparatus including an introducer cartridge and a delivery catheter and method for delivering th.
Dormandy ; Jr. Ray H. (San Bruno CA) Berlo Marcelyn A. (San Francisco CA), Embolization device and apparatus including an introducer cartridge and method for delivering the same.
Conston Stanley R. (San Carlos CA) Dapper Gregory S. (Newark CA) Murphy Aileen L. (Menlo Park CA) Raeder-Devens Jennifer (Oakland CA) Yamamoto Ronald (San Francisco CA), Embolization plugs for blood vessels.
Takahashi Toru (Shizuoka-ken JPX) Nakamura Hideki (Kanagawa-ken JPX) Goto Katsuya (Fukuoka-ken JPX), High polymer gel and vascular lesion embolizing material comprising the same.
Rhee Woonza M. ; Berg Richard A. ; Chu George H. ; DeLustro Frank A. ; Jolivette Dan M. ; McCullough Kimberly A., Injectable or implantable biomaterials for filling or blocking lumens and voids of the body.
Pasztor, Emil; Lazar, Laszlo; Nagy, Jozsef; Pallosy nee Becker, Katalin, Pharmaceutically acceptable silicon rubber and therapeutical set and the use thereof for surgical embolization.
Hyon Suong-Hyu (Tamatsukurimotomachi JPX) Ikada Yoshito (Tamatsukurimotomachi JPX), Porous and transparent poly(vinyl alcohol) gel and method of manufacturing the same.
Dormandy ; Jr. Ray H. (South San Francisco CA) Bell Julie D. (South San Francisco CA), System for artificial vessel embolization and devices for use therewith.
Ritchart Mark (Santa Clara CA) Mariant Mike (Santa Clara CA) Sepetka Ivan (Santa Clara CA) Engelson Erik (Portola Valley CA), Vaso-occlusion coil and method.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.